当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析 - 现金流量表

和邦生物

(603077)

  

流通市值:170.45亿  总市值:170.45亿
流通股本:88.31亿   总股本:88.31亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,177,564,048.671,634,049,492.447,480,057,304.35,238,258,922.96
  收到的税费返还66,091,235.8513,782,527.2337,242,301.9625,806,199.3
  收到其他与经营活动有关的现金59,706,667.8315,728,987.06162,332,673.3466,223,464.44
  经营活动现金流入小计3,303,361,952.351,663,561,006.737,679,632,279.65,330,288,586.7
  购买商品、接受劳务支付的现金2,583,031,345.511,469,592,018.355,829,688,440.224,386,716,484.23
  支付给职工以及为职工支付的现金330,340,754.45171,905,988.29884,036,822.91704,791,211.13
  支付的各项税费172,153,568.4858,277,337.98345,101,527.6260,840,307.38
  支付其他与经营活动有关的现金72,366,744.5418,377,070.81152,874,101.7115,163,399.48
  经营活动现金流出小计3,157,892,412.981,718,152,415.437,211,700,892.435,467,511,402.22
  经营活动产生的现金流量净额145,469,539.37-54,591,408.7467,931,387.17-137,222,815.52
二、投资活动产生的现金流量:
  收回投资收到的现金77,052,422.39-27,523,493.8522,581,922.2
  取得投资收益收到的现金1,120,0001,120,0001,806,347.01843,852.71
  处置固定资产、无形资产和其他长期资产收回的现金净额565,396.01565,396.012,698,447.4629,699
  收到的其他与投资活动有关的现金40,056,743.0829,165,751.3713,543,230.71700,000
  投资活动现金流入小计118,794,561.4830,851,147.3845,571,519.0324,155,473.91
  购建固定资产、无形资产和其他长期资产支付的现金469,833,381.35330,976,242.351,116,226,426.99545,005,408.01
  投资支付的现金34,295,953.4826,000,000283,780,066.18203,931,308.21
  支付其他与投资活动有关的现金37,909,960.0311,955,831.432,684,506.6339,728,300.89
  投资活动现金流出小计542,039,294.86368,932,073.751,432,690,999.8788,665,017.11
  投资活动产生的现金流量净额-423,244,733.38-338,080,926.37-1,387,119,480.77-764,509,543.2
三、筹资活动产生的现金流量:
  吸收投资收到的现金120,000---
  其中:子公司吸收少数股东投资收到的现金120,000---
  取得借款收到的现金2,683,676,713.762,234,676,713.767,981,179,805.552,710,072,723.29
  收到其他与筹资活动有关的现金73,931,506.5744,531,637.09159,130,243.5159,130,243.5
  筹资活动现金流入小计2,757,728,220.332,279,208,350.858,140,310,049.052,869,202,966.79
  偿还债务支付的现金2,093,307,295.781,323,196,478.751,491,322,847.51,243,925,323.58
  分配股利、利润或偿付利息支付的现金60,858,628.4230,496,071.9246,664,095.3361,649,487.15
  支付其他与筹资活动有关的现金322,699,727.46320,494,433.531,555,112,829.41,195,922,516.17
  筹资活动现金流出小计2,476,865,651.661,674,186,984.183,293,099,772.232,501,497,326.9
  筹资活动产生的现金流量净额280,862,568.67605,021,366.674,847,210,276.82367,705,639.89
四、汇率变动对现金及现金等价物的影响-7,911,681.591,784,946.918,709,035.49-4,277,081
五、现金及现金等价物净增加额-4,824,306.93214,133,978.53,946,731,218.71-538,303,799.83
  加:期初现金及现金等价物余额6,851,563,060.796,851,563,060.792,904,831,842.082,904,831,842.08
  期末现金及现金等价物余额6,846,738,753.867,065,697,039.296,851,563,060.792,366,528,042.25
补充资料:
  净利润40,239,432.36--70,744,609.93-
  资产减值准备6,302,681.31-128,021,291.49-
  固定资产和投资性房地产折旧450,354,004.91-920,635,825.49-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧450,354,004.91-920,635,825.49-
  无形资产摊销26,828,454.4-54,748,148.57-
  长期待摊费用摊销196,226.4-5,000,881.64-
  处置固定资产、无形资产和其他长期资产的损失-1,237,409.73--1,168,756.89-
  固定资产报废损失41,523.13-131,511.32-
  财务费用54,443,201.89-62,136,404.75-
  投资损失-302,393.09-5,670,300.35-
  递延所得税-11,319,132.38--69,094,247.39-
  其中:递延所得税资产减少-13,606,312.39--74,035,323.03-
    递延所得税负债增加2,287,180.01-4,941,075.64-
  存货的减少338,040,532.42--240,336,248.6-
  经营性应收项目的减少19,921,903.48--53,392,819.13-
  经营性应付项目的增加-792,939,171.59--319,993,941.36-
  其他--31,826,048.72-
  现金的期末余额6,846,738,753.86-6,851,563,060.79-
  减:现金的期初余额6,851,563,060.79-2,904,831,842.08-
  现金及现金等价物的净增加额-4,824,306.93-3,946,731,218.71-
公告日期2025-08-202025-04-292025-04-292024-10-31
审计意见(境内)标准无保留意见
TOP↑